Institutional members access full text with Ovid®

HIV-infected adolescents in southern Africa can achieve good treatment outcomes: results from a retrospective cohort study

Shroufi, Amira; Gunguwo, Hilaryb,c; Dixon, Markb,c; Nyathi, Maryb,c; Ndebele, Wedub,c; Saint-Sauveur, Jean-Françoisa; Taziwa, Fabiana; Ferreyra, Ceciliaa; Viñoles, Mari-Carmena; Ferrand, Rashida A.d

doi: 10.1097/QAD.0b013e32836149ea
Epidemiology and Social

Objectives: In this study we examine whether adolescents treated for HIV/AIDS in southern Africa can achieve similar treatment outcomes to adults.

Design: We have used a retrospective cohort study design to compare outcomes for adolescents and adults commencing antiretroviral therapy (ART) between 2004 and 2010 in a public sector hospital clinic in Bulawayo, Zimbabwe.

Methods: Cox proportional hazards modelling was used to investigate risk factors for death and loss to follow-up (LTFU) (defined as missing a scheduled appointment by ≥3months).

Results: One thousand, seven hundred and seventy-six adolescents commenced ART, 94% having had no previous history of ART. The median age at ART initiation was 13.3 years. HIV diagnosis in 97% of adolescents occurred after presentation with clinical disease and a higher proportion had advanced HIV disease at presentation compared with adults [WHO Stage 3/4 disease (79.3 versus 65.2%, P < 0.001)]. Despite this, adolescents had no worse mortality than adults, assuming 50% mortality among those LTFU (6.4 versus 7.3 per 100 person-years, P = 0.75) with rates of loss to follow-up significantly lower than in adults (4.8 versus 9.2 per 100 person-years, P < 0.001). Among those who were followed for 5 years or more, 5.8% of adolescents switched to a second-line regimen as a result of treatment failure, compared with 2.1% of adults (P < 0.001).

Conclusion: With adolescent-focused services, it is feasible to achieve good outcomes for adolescents in large-scale ART programs in sub-Saharan Africa. However, adolescents are at high risk of treatment failure, which compromises future drug options. Interventions to address poor adherence in adolescence should be prioritized.

aMedecins Sans Frontieres, Operation Center Barcelona Athens, Belgravia, Harare

bMpilo OI/ART Clinic

cFaculty of Medicine, National University of Science and Technology, Bulawayo, Zimbabwe

dLondon School of Hygiene and Tropical Medicine, London, UK.

Correspondence to Dr Amir Shroufi, Médecins Sans Frontières, 3 Natal Road, Belgravia, Harare, Zimbabwe. E-mail: amir.shroufi@doctors.org.uk

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/3.0.

Received November 5, 2012

Accepted March 15, 2013

© 2013 Lippincott Williams & Wilkins, Inc.